Literature DB >> 18639328

Penile metastasis secondary to nasal NK/T-cell lymphoma.

Shih-Kai Lan1, Chih-Wen Lin, Hsu-Chueh Ho, Moon-Sing Lee, Jeh-En Tzeng, Yu-Chieh Su.   

Abstract

We report on a case of recurrent nasal NK/T-cell lymphoma in a patient who presented with a penile mass. No obvious other recurrent site except the penile lesion was noted. Metastatic penile lymphoma is extremely rare. We describe the image findings and clinical course of this case.

Entities:  

Mesh：

Year:  2008        PMID： 18639328     DOI： 10.1016/j.urology.2008.05.029

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  5 in total

1.  Malignant priapism secondary to metastatic prostate cancer: a case report and review of literature.

Authors:  Yu-Hsiang Lin; Jerry J Kim; Ned B Stein; Mohit Khera
Journal:  Rev Urol       Date:  2011

2.  Penile metastasis secondary to nasal-type extranodal natural killer/T-cell lymphoma: A case report and review of the literature.

Authors:  Yanan Li; Xiaorui Fu; Jingjing Wu; Chang Yu; Zhaoming Li; Zhenchang Sun; Jiaqin Yan; Feifei Nan; Xundong Zhang; Ling Li; Xin Li; Lei Zhang; Wencai Li; Guannan Wang; Mingzhi Zhang
Journal:  Oncol Lett       Date:  2018-03-16       Impact factor: 2.967

Review 3.  Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature.

Authors:  Xiaotian Wang; Zimu Gong; Shawn Xiang Li; Wei Yan; Yongsheng Song
Journal:  BMC Urol       Date:  2017-09-06       Impact factor: 2.264

4.  A Case Report of Primary Nasal Natural Killer (NK)/T-Cell Lymphoma in an African American Patient Presenting with Hemophagocytic Syndrome.

Authors:  Bowei Tan; Cherif Abdelmalek; James E O'Donnell; Thomas Toltaku; Rashid Chaudhry; Jen C Wang; Vladimir Gotlieb
Journal:  Am J Case Rep       Date:  2017-02-14

Review 5.  Prognosis of men with penile metastasis and malignant priapism: a systematic review.

Authors:  Andrea Cocci; Oliver W Hakenberg; Tommaso Cai; Gabriella Nesi; Lorenzo Livi; Beatrice Detti; Andrea Minervini; Girolamo Morelli; Marco Carini; Sergio Serni; Mauro Gacci
Journal:  Oncotarget       Date:  2017-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.